Key Insights

Highlights

Treatment Research

2 treatments under study, led by Laboratory Biomarker Analysis

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02140021Not ApplicableTerminated

Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer

Showing all 1 trials

Research Network

Common Treatments

  • Laboratory Biomarker Analysis1
  • Biospecimen Collection1

Active Sponsors

  • National Cancer Institute (NCI)1
  • M.D. Anderson Cancer Center1

Top Investigators

Related Conditions

  • Stage Iiia Cervical Cancer Ajcc V81
  • Stage Iib Vaginal Cancer Ajcc V81
  • Stage Ivb Vaginal Cancer Ajcc V81
  • Stage Iii Vaginal Cancer Ajcc V81
  • Stage Ii Vaginal Cancer Ajcc V81

Activity Timeline